罗氏Elecsys® pTau181血液检测成为FDA批准的首个可用于初级保健排除阿尔茨海默病相关淀粉样蛋白病变的检测方法——PR Newswire报道。

Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology  PR Newswire